Impact of baseline high-sensitive C-reactive protein on the regression of coronary atherosclerosis in patients treated with combined lipid and blood pressure-lowering therapy: Insight from MILLION stu
Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy